You are viewing an archived page on our old website. Click here to visit our new website.

Home | WFF History | Join/Donate | Current Voices | Liturgical Calendar | What's New | Affirmation | James Hitchcock's Column | Church Documents | Search |


Statement of US Bishops on New Stem-cell Breakthrough

U.S. Conference of Catholic Bishops
Department of Communications

DATE:            November 20, 2007
FROM:           Kevin Moore
 
O:  202-541-3206
C:  203-788-8497
                                                                   
 FOR IMMEDIATE RELEASE
  
STEM CELL BREAKTHROUGH ADVANCES SCIENCE WITHOUT “ETHICAL LANDMINES,” SAYS CARDINAL

WASHINGTON--The following statement was released today by Cardinal Justin Rigali of Philadelphia, chairman of the Committee for Pro-Life Activities at the United States Conference of Catholic Bishops:
 
“Studies published this week in the journals Cell and Science offer new hope for advancing stem cell research and therapies while fully respecting the dignity of human life.
 
“Scientists in Japan and Wisconsin used four genes to ‘reprogram’ ordinary adult human cells, creating ‘induced pluripotent stem cells’ (iPS cells).  James Thomson, head of the Wisconsin team and the founder of human embryonic stem cell research, says these cells ‘meet the defining criteria’ for pluripotent human embryonic stem cells, ‘with the significant exception that the iPS cells are not derived from embryos.’
 
“Thus the goal sought for years through failed attempts at human cloning – the production of ‘pluripotent’ stem cells that are an exact genetic match to a patient – has been brought within reach by an ethical procedure. This technology avoids the many ethical landmines associated with embryonic stem cell research: it does not clone or destroy human embryos, does not harm or exploit women for their eggs, and does not blur the line between human beings and other species through desperate efforts to make human embryos using animal eggs.  Ian Wilmut, head of the team that cloned ‘Dolly’ the sheep, now says he is abandoning efforts at human ‘therapeutic cloning’ to pursue this adult cell reprogramming avenue instead, because it is technically superior as well as ‘easier to accept socially.’
 
“I am grateful today for scientists who took up the challenge of finding morally acceptable ways to pursue stem cell research, and for government leaders who have encouraged and funded such avenues.  This advance reminds us once again that medical progress and respect for human life are not in conflict; they can and should support and enrich one another for the good of all.”


**Women for Faith & Family operates solely on your generous donations!

WFF is a registered 501(c)(3) non-profit organization. Donations are tax deductible.

Voices copyright © 1999-Present Women for Faith & Family. All rights reserved.

PERMISSION GUIDELINES

All material on this web site is copyrighted and may not be copied or reproduced without prior written permission from Women for Faith & Family,except as specified below.

Personal use
Permission is granted to download and/or print out articles for personal use only.

Quotations
Brief quotations (ca 500 words) may be made from the material on this site, in accordance with the “fair use” provisions of copyright law, without prior permission. For these quotations proper attribution must be made of author and WFF + URL (i.e., “Women for Faith & Family – www.wf-f.org.)

Attribution
Generally, all signed articles or graphics must also have the permission of the author. If a text does not have an author byline, Women for Faith & Family should be listed as the author. For example: Women for Faith & Family (St Louis: Women for Faith & Family, 2005 + URL)

Link to Women for Faith & Family web site.
Other web sites are welcome to establish links to www.wf-f.org or to individual pages within our site.


Back to top -- Home -- Back to Stem Cell Page -- Back to Medicine & Morality

Women for Faith & Family
PO Box 300411 - St. Louis, MO 63130
Phone: 314-863-8385 | Fax: 314-863-5858 | Email

You are viewing an archived page on our old website. Click here to visit our new website.